2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 5g

1-Acetyl-N-cyclopropylpiperidin-4-amine, 95.0%, 10g

6-Bromo-7-methyl-2h,3h-[1,2,4]triazolo[4,3-a]pyridin-3-one, 97%, 500mg

2,4-Hexadiyne>98.0%(GC)1g

Ethyl 4-((tert-butoxycarbonyl)amino)-1-methyl-1H-imidazole-2-carboxylate, 95.0%, 100mg

3-Allyl-1,5-naphthyridine, 95+%, 250mg

H-Arg(NO2)-OH, 95%, 10g

Piperazin-1-yl(thiophen-3-yl)acetic acid dihydrochloride, 95.0%, 250mg

2-Ethoxyethanol, min 99%, for synthesis, 2.5 L, glass packaging

n-{[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}cyclopropanamine, 98%, 100mg

Cbz-D-(-)-Phenylglycine, 95.0%, 25g

4-(4-Bromopyridin-2-yl)morpholine, 97.0%, 5g

(S)-2,2'-Bis[bis(3,5-dimethylphenyl)phosphino]-4,4',6,6'-tetramethoxy)-1,1'-biphenyl, 97%, 100mg